Stonebridge Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-32,123
Closed -$1.91M 99
2022
Q1
$1.91M Sell
32,123
-350
-1% -$20.8K 0.69% 39
2021
Q4
$2.36M Sell
32,473
-2,900
-8% -$211K 0.82% 34
2021
Q3
$2.47M Sell
35,373
-690
-2% -$48.2K 0.91% 32
2021
Q2
$2.48M Buy
36,063
+200
+0.6% +$13.8K 0.9% 33
2021
Q1
$2.32M Buy
35,863
+1,300
+4% +$84K 0.88% 33
2020
Q4
$2.01M Sell
34,563
-72
-0.2% -$4.2K 0.83% 34
2020
Q3
$2.19M Buy
34,635
+6,255
+22% +$395K 1.01% 31
2020
Q2
$2.16M Sell
28,380
-2,268
-7% -$173K 1.11% 30
2020
Q1
$2.29M Sell
30,648
-1,800
-6% -$135K 1.28% 25
2019
Q4
$2.11M Sell
32,448
-6,335
-16% -$412K 0.92% 34
2019
Q3
$2.46M Sell
38,783
-15,455
-28% -$980K 1.14% 27
2019
Q2
$3.66M Sell
54,238
-22,319
-29% -$1.51M 1.44% 19
2019
Q1
$4.98M Buy
76,557
+6,626
+9% +$431K 1.82% 18
2018
Q4
$4.38M Buy
69,931
+8,356
+14% +$523K 1.75% 19
2018
Q3
$4.75M Sell
61,575
-985
-2% -$76K 1.63% 20
2018
Q2
$4.56M Buy
62,560
+11,615
+23% +$846K 1.63% 21
2018
Q1
$3.83M Sell
50,945
-2,730
-5% -$205K 1.4% 24
2017
Q4
$4.24M Buy
53,675
+11,880
+28% +$939K 1.51% 23
2017
Q3
$3.39M Sell
41,795
-11,315
-21% -$917K 1.27% 25
2017
Q2
$3.76M Sell
53,110
-8,570
-14% -$607K 1.44% 22
2017
Q1
$4.19M Buy
61,680
+6,450
+12% +$438K 1.69% 19
2016
Q4
$3.96M Buy
55,230
+430
+0.8% +$30.8K 1.67% 19
2016
Q3
$4.34M Buy
54,800
+26,040
+91% +$2.06M 1.86% 20
2016
Q2
$2.4M Buy
28,760
+6,290
+28% +$525K 1.09% 30
2016
Q1
$2.06M Buy
22,470
+14,530
+183% +$1.33M 0.88% 32
2015
Q4
$803K Buy
7,940
+800
+11% +$80.9K 0.34% 57
2015
Q3
$701K Buy
7,140
+725
+11% +$71.2K 0.32% 60
2015
Q2
$751K Buy
6,415
+1,805
+39% +$211K 0.31% 69
2015
Q1
$452K Hold
4,610
0.18% 107
2014
Q4
$435K Sell
4,610
-500
-10% -$47.2K 0.17% 115
2014
Q3
$544K Buy
5,110
+10
+0.2% +$1.07K 0.21% 98
2014
Q2
$423K Buy
+5,100
New +$423K 0.16% 120